Wednesday, February 19, 2020
Home News Pharma News

Pharma News

Health Europa brings you the latest Pharma News the field of European Healthcare & Social Care Policy.

man with bad odour in elevator with people

Fish Odour Syndrome: Dermetel aims to give patients a breath of fresh air

Dermetel is launching two Phase I clinical trials that focus on the rare disease, Trimethylaminuria or more commonly known, fish odour syndrome. Fish odour syndrome...
Partnership to reduce sepsis in the UK

New partnership announced today is set to reduce the impact of sepsis in the UK

Beckman Coulter, the global leader in clinical diagnostics, announces today its partnership with South West London Pathology (SWLP) to reduce the impact of sepsis in...
Want to hear the latest developments regarding Tetra’s hepatocellular carcinoma drug?

Want to hear the latest developments regarding Tetra’s hepatocellular carcinoma drug?

Responsible for 80% of primary malignant liver tumours in adults, hepatocellular carcinoma is a common form of liver cancer – but did you know...
Ketamine may hold potential as treatment for Autism and Tourette's

Ketamine may hold potential as treatment for autism and Tourette’s

To this day there is no known cure for either autism or Tourette’s syndrome, however, new research has revealed how a common anaesthetic could...
Nerve pain drug could help restore limb function after spinal cord injury

Nerve pain drug could help restore limb function after spinal cord injury

A mouse study has shown that nerve pain drug gabapentin promotes regeneration of neural circuits. New research in mice suggests that long-term treatment with gabapentin,...
World’s first magic mushroom nasal spray for PTSD and depression

World’s first magic mushroom nasal spray for PTSD and depression

PTSD and depression are two conditions that are being trialled for treatment with psilocybin. A ‘magic mushroom’ nasal spray has been designed to make microdosing...
Clinical trials: FDA marks psilocybin for depression treatment

Clinical trials: FDA marks psilocybin for depression treatment

The FDA designation represents a major step forward in mental health research and for patients suffering from depression. A non-profit medical research centre, the Usona...
New antibiotic on the horizon to combat drug resistance

New antibiotic on the horizon to combat drug resistance

Today, more and more bacterial pathogens of infectious diseases are becoming resistant to customary antibiotics. A new discovery, from an international team of researchers, with...
Crohn's disease: how associated bacteria develop drug resistance

Crohn’s disease: how associated bacteria develop drug resistance

Many patients with Crohn's disease develop resistance to treatments. Researchers have looked at how Chron’s disease-related bacteria can form drug resistance. They found that bacteria associated...
Why veterinarians should be at the heart of the drug resistance fightback

Why veterinarians should be at the heart of the drug resistance fightback

When antibiotic resistance could be responsible for up to 10 million deaths a year by 2050 if left unchecked, it is natural to want...
General Election manifesto for UK pharmaceutical industry launched

General Election manifesto for UK pharmaceutical industry launched

The Association of the British Pharmaceutical Industry has launched its General Election 2020 Manifesto for Medicine. The UK pharmaceutical industry body is calling on all...
Gene patent reform in the US and the knock-on effect in Europe

Gene patent reform in the US and the knock-on effect in Europe

Rosie McDowell, an attorney at EIP shares her thoughts on gene patent reform and the potential impact it might have across the globe. This year...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest